Head-to-Head

Eli Lilly & Co. vs. Viatris Inc. Common Stock

LLY

Eli Lilly & Co.

$1184.83 +0.12%

VS VTRS

Viatris Inc. Common Stock

$18.27 +2.47%

Eli Lilly & Co. (LLY) comes out ahead, leading on 6 of 9 compared factors.

Size & Scale

LLYVTRS
Market Cap $1.05 trillion $20.48 billion
Revenue (TTM) $79.67 billion $14.74 billion
Net Income (TTM) $26.71 billion $-410,700,000

LLY leads on 3 of 3 size & scale factors.

Valuation

LLYVTRS
P/E Ratio 39.77 —
Price / Book 31.14 1.44
Price / Sales 13.24 1.39

VTRS leads on 2 of 2 valuation factors.

Profitability

LLYVTRS
Net Margin 33.53% -2.79%
Return on Equity 78.84% -2.88%

LLY leads on 2 of 2 profitability factors.

Dividend

LLYVTRS
Dividend Yield 0.58% 2.63%
Payout Ratio 23.23 —

VTRS leads on 1 of 1 dividend factors.

Risk & Sentiment

LLYVTRS
Short Interest 1.29% 4.03%

LLY leads on 1 of 1 risk & sentiment factors.

Dig deeper: LLY overview, LLY financials, VTRS overview, VTRS financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.